Page last updated: 2024-08-26

(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane and methamphetamine

(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane has been researched along with methamphetamine in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (29.41)18.2507
2000's12 (70.59)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inosaka, T; Numachi, Y; Sato, M; Yoshida, S1
Dannals, RF; Hatzidimitriou, G; Mathews, WB; McCann, UD; Musachio, J; Ravert, HT; Ricaurte, GA; Villemagne, V; Wong, DF; Yuan, J1
Dannals, RF; McCann, UD; Ricaurte, GA; Villemagne, V; Wong, DF; Yokoi, F1
Fleckenstein, AE; Hanson, GR; Kokoshka, JM; Vaughan, RA1
Harvey, DC; Huang, SC; Lacan, G; Melega, WP; Phelps, ME1
Desalles, AA; Lacan, G; Melega, WP; Phelps, ME1
Callahan, B; Hatzidimitriou, G; Kim, S; Ricaurte, GA; Westphalen, R; Yuan, J1
Fleckenstein, AE; Hanson, GR; Riddle, EL; Sandoval, V; Ugarte, YV1
Futatsubashi, M; Iyo, M; Matsunaga, T; Mori, N; Okada, H; Ouchi, Y; Sekine, Y; Takei, N; Tsukada, H; Yoshikawa, E1
Brown, JM; Fleckenstein, AE; Gibb, JW; Hansen, JP; Hanson, GR; Riddle, EL; Sandoval, V1
Cho, AK; Kuczenski, R; Melega, WP; O'Neil, ML; Segal, DS1
Futatsubashi, M; Iyo, M; Minabe, Y; Mori, N; Nakamura, K; Okada, H; Ouchi, Y; Sekine, Y; Suzuki, K; Takei, N; Tsukada, H; Yoshikawa, E1
Becker, KG; Cheadle, C; Donovan, DM; McCann, UD; Mechan, AO; Ricaurte, GA; Tong, L; Xie, T; Yuan, J1
Cho, AK; Kuczenski, R; Lacan, G; Melega, WP; O'Neil, ML; Segal, DS1
Cho, AK; Fairbanks, LA; Jorgensen, MJ; Laćan, G; Melega, WP; Morton, G; Pham, J; Way, BM1
Abbey, R; Alexander, M; Brasic, J; Dannals, RF; Kumar, A; Kuwabara, H; McCann, UD; Palermo, M; Ricaurte, GA; Wong, DF; Ye, W1
Iida, A; Inoue, N; Kakiuchi, T; Kondo, Y; Muramatsu, S; Nakano, I; Nakayama, T; Okuno, T; Ono, F; Suzuki, Y; Takino, N; Terao, K; Tsukada, H1

Other Studies

17 other study(ies) available for (3h)2-carbomethoxy-3-(4-fluorophenyl)tropane and methamphetamine

ArticleYear
Changes of drug biodistribution in the methamphetamine sensitized rat brain.
    Clinical neuropharmacology, 1992, Volume: 15 Suppl 1 Pt A

    Topics: Amphetamines; Animals; Brain; Cocaine; Iofetamine; Male; Methamphetamine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Tissue Distribution

1992
Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1998, Jan-01, Volume: 18, Issue:1

    Topics: Animals; Carbon Radioisotopes; Carrier Proteins; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Humans; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Neostriatum; Nerve Tissue Proteins; Neurotoxins; Papio; Substance-Related Disorders; Tomography, Emission-Computed; Tritium

1998
Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1998, Oct-15, Volume: 18, Issue:20

    Topics: Adult; Amphetamine-Related Disorders; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Central Nervous System Stimulants; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Middle Aged; Neostriatum; Nerve Tissue Proteins; Parkinson Disease, Secondary; Propiophenones; Tomography, Emission-Computed

1998
Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters.
    European journal of pharmacology, 1998, Nov-20, Volume: 361, Issue:2-3

    Topics: Animals; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Nerve Tissue Proteins; Nucleus Accumbens; Rats; Rats, Sprague-Dawley

1998
Dizocilpine and reduced body temperature do not prevent methamphetamine-induced neurotoxicity in the vervet monkey: [11C]WIN 35,428 - positron emission tomography studies.
    Neuroscience letters, 1998, Dec-11, Volume: 258, Issue:1

    Topics: Animals; Carbon Radioisotopes; Carrier Proteins; Chlorocebus aethiops; Cocaine; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Hypothermia; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Nerve Tissue Proteins; Neuroprotective Agents; Tomography, Emission-Computed

1998
Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
    Synapse (New York, N.Y.), 2000, Mar-15, Volume: 35, Issue:4

    Topics: Animals; Carbon Radioisotopes; Carrier Proteins; Caudate Nucleus; Chlorocebus aethiops; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Glial Cell Line-Derived Neurotrophic Factor; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Nerve Growth Factors; Nerve Tissue Proteins; Neurotoxins; Putamen; Tomography, Emission-Computed

2000
Toward development of an in vitro model of methamphetamine-induced dopamine nerve terminal toxicity.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 293, Issue:2

    Topics: Animals; Cocaine; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fenfluramine; Glutamic Acid; In Vitro Techniques; Kinetics; Male; Methamphetamine; Neostriatum; Presynaptic Terminals; Protein Kinase C; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Synaptosomes; Temperature; Time Factors

2000
Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2001, Feb-15, Volume: 21, Issue:4

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Biological Transport; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; In Vitro Techniques; Male; Membrane Glycoproteins; Membrane Potentials; Membrane Transport Proteins; Methamphetamine; Methylphenidate; Models, Biological; Nerve Tissue Proteins; Norepinephrine; Onium Compounds; Organophosphorus Compounds; Phosphorylation; Protein Kinase C; Rats; Rats, Sprague-Dawley; Serotonin; Synaptosomes

2001
Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.
    The American journal of psychiatry, 2001, Volume: 158, Issue:8

    Topics: Adult; Behavior, Addictive; Brain Chemistry; Brief Psychiatric Rating Scale; Carbon Radioisotopes; Carrier Proteins; Caudate Nucleus; Cerebellar Cortex; Cocaine; Dopamine Plasma Membrane Transport Proteins; Humans; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Nerve Tissue Proteins; Nucleus Accumbens; Prefrontal Cortex; Psychoses, Substance-Induced; Putamen; Substance-Related Disorders; Tomography, Emission-Computed

2001
Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 300, Issue:3

    Topics: Animals; Biological Transport; Body Temperature; Cell Membrane; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Hallucinogens; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neuropeptides; Neurotoxins; Rats; Rats, Sprague-Dawley; Synaptic Vesicles; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins

2002
Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2003, Volume: 28, Issue:10

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Binding Sites; Body Temperature; Brain Chemistry; Central Nervous System Stimulants; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Homovanillic Acid; Male; Methamphetamine; Motor Activity; Neostriatum; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Tetrabenazine; Time Factors; Tritium

2003
Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms.
    The American journal of psychiatry, 2003, Volume: 160, Issue:9

    Topics: Adult; Amphetamine-Related Disorders; Amygdala; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Frontal Lobe; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Nerve Tissue Proteins; Prefrontal Cortex; Psychoses, Substance-Induced; Tomography, Emission-Computed

2003
Identification and characterization of metallothionein-1 and -2 gene expression in the context of (+/-)3,4-methylenedioxymethamphetamine-induced toxicity to brain dopaminergic neurons.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004, Aug-11, Volume: 24, Issue:32

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Blotting, Northern; Brain; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Illicit Drugs; Male; Metallothionein; Methamphetamine; Mice; Mice, Knockout; Neurons; Neuroprotective Agents; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Time Factors

2004
Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
    Synapse (New York, N.Y.), 2006, Volume: 60, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Amphetamine-Related Disorders; Animals; Body Temperature; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Cocaine; Dopamine Uptake Inhibitors; Gas Chromatography-Mass Spectrometry; Homovanillic Acid; Male; Methamphetamine; Microdialysis; Neostriatum; Rats; Rats, Sprague-Dawley

2006
Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:6

    Topics: Analysis of Variance; Animals; Autoradiography; Behavior, Animal; Benzazepines; Brain; Brain Chemistry; Central Nervous System Stimulants; Chlorocebus aethiops; Cocaine; Disease Models, Animal; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Methamphetamine; Neurotoxicity Syndromes; Protein Binding; Raclopride; Social Behavior; Tritium

2008
Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users.
    Synapse (New York, N.Y.), 2008, Volume: 62, Issue:2

    Topics: Adult; Amphetamine-Related Disorders; Analysis of Variance; Cocaine; Cognition; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Female; Humans; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Parkinson Disease, Secondary; Positron-Emission Tomography

2008
Multitracer assessment of dopamine function after transplantation of embryonic stem cell-derived neural stem cells in a primate model of Parkinson's disease.
    Synapse (New York, N.Y.), 2009, Volume: 63, Issue:7

    Topics: Animals; Carbon Radioisotopes; Cells, Cultured; Cocaine; Disease Models, Animal; Dopamine; Dopamine Agents; Embryonic Stem Cells; Levodopa; Macaca fascicularis; Methamphetamine; Movement Disorders; Neurons; Parkinson Disease; Positron-Emission Tomography; Putamen; Raclopride; Tyrosine 3-Monooxygenase

2009